Minimally Interrupted Non-Vitamin K Antagonist Oral Anticoagulants vs. Bridging Therapy and Uninterrupted Vitamin K Antagonists During Atrial Fibrillation Ablation: A Retrospective Single-Center Study

Objectives: Although the latest international guidelines recommend the use of uninterrupted non-vitamin K antagonist oral anticoagulants (NOAC) during atrial fibrillation (AF) ablation, it does not reflect current clinical practice, as most centers still use a minimally interrupted NOAC strategy. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Lihong, Liu, Haiyan, Deng, Hai, Zhan, Xianzhang, Fang, Xianhong, Liao, Hongtao, Liu, Yang, Fu, Lu, Fu, Zuyi, Liu, Huiyi, Wu, Shulin, Xue, Yumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287181/
https://www.ncbi.nlm.nih.gov/pubmed/32582721
http://dx.doi.org/10.3389/fmed.2020.00197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287181/
https://www.ncbi.nlm.nih.gov/pubmed/32582721
http://dx.doi.org/10.3389/fmed.2020.00197

Ejemplares similares